Prognostic implications of biventricular strain measurement in COVID-19 patients by speckle-tracking echocardiography.
COVID-19
echocardiography
prognosis
speckle-tracking echocardiography
strain
Journal
Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
revised:
23
07
2021
received:
12
04
2021
accepted:
30
07
2021
pubmed:
7
8
2021
medline:
16
10
2021
entrez:
6
8
2021
Statut:
ppublish
Résumé
Recent reports have indicated the beneficial role of strain measurement in COVID-19 patients. To determine the association between right and left global longitudinal strain (RVGLS, LVGLS) and COVID-19 patients' outcomes. Hospitalized COVID-19 patients between June and August 2020 were included. Two-dimensional echocardiography and biventricular global longitudinal strain measurement were performed. The outcome measure was defined as mortality, ICU admission, and need for intubation. Appropriate statistical tests were used to compare different groups. In this study 207 patients (88 females) were enrolled. During 64 ± 4 days of follow-up, 22 (10.6%) patients died. Mortality, ICU admission, and intubation were significantly associated with LVGLS and RVGLS tertiles. LVGLS tertiles could predict poor outcome with significant odds ratios in the total population (OR = 0.203, 95% CI: 0.088-0.465; OR = 0.350, 95% CI: 0.210-0.585; OR = 0.354, 95% CI: 0.170-0.736 for mortality, ICU admission, and intubation). Although odds ratios of LVGLS for the prediction of outcome were statistically significant among hypertensive patients, these odds ratios did not reach significance among non-hypertensive patients. RVGLS tertiles revealed significant odds ratios for the prediction of mortality (OR = 0.322, 95% CI: 0.162-0.640), ICU admission (OR = 0.287, 95% CI: 0.166-0.495), and need for intubation (OR = 0.360, 95% CI: 0.174-0.744). Odds ratios of RVGLS remained significant even after adjusting for hypertension when considering mortality and ICU admission. RVGLS and LVGLS can be acceptable prognostic factors to predict mortality, ICU admission, and intubation in hospitalized COVID-19 patients. However, RVGLS seems more reliable, as it is not confounded by hypertension.
Sections du résumé
BACKGROUND
BACKGROUND
Recent reports have indicated the beneficial role of strain measurement in COVID-19 patients.
HYPOTHESIS
OBJECTIVE
To determine the association between right and left global longitudinal strain (RVGLS, LVGLS) and COVID-19 patients' outcomes.
METHODS
METHODS
Hospitalized COVID-19 patients between June and August 2020 were included. Two-dimensional echocardiography and biventricular global longitudinal strain measurement were performed. The outcome measure was defined as mortality, ICU admission, and need for intubation. Appropriate statistical tests were used to compare different groups.
RESULTS
RESULTS
In this study 207 patients (88 females) were enrolled. During 64 ± 4 days of follow-up, 22 (10.6%) patients died. Mortality, ICU admission, and intubation were significantly associated with LVGLS and RVGLS tertiles. LVGLS tertiles could predict poor outcome with significant odds ratios in the total population (OR = 0.203, 95% CI: 0.088-0.465; OR = 0.350, 95% CI: 0.210-0.585; OR = 0.354, 95% CI: 0.170-0.736 for mortality, ICU admission, and intubation). Although odds ratios of LVGLS for the prediction of outcome were statistically significant among hypertensive patients, these odds ratios did not reach significance among non-hypertensive patients. RVGLS tertiles revealed significant odds ratios for the prediction of mortality (OR = 0.322, 95% CI: 0.162-0.640), ICU admission (OR = 0.287, 95% CI: 0.166-0.495), and need for intubation (OR = 0.360, 95% CI: 0.174-0.744). Odds ratios of RVGLS remained significant even after adjusting for hypertension when considering mortality and ICU admission.
CONCLUSION
CONCLUSIONS
RVGLS and LVGLS can be acceptable prognostic factors to predict mortality, ICU admission, and intubation in hospitalized COVID-19 patients. However, RVGLS seems more reliable, as it is not confounded by hypertension.
Identifiants
pubmed: 34355809
doi: 10.1002/clc.23708
pmc: PMC8420186
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1475-1481Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.
Références
Int J Cardiovasc Imaging. 2021 Apr;37(4):1349-1360
pubmed: 33211242
Crit Care Med. 2014 Jun;42(6):e432-40
pubmed: 24633187
Future Cardiol. 2021 Jul;17(4):663-667
pubmed: 32749151
Eur Heart J. 2021 Feb 11;42(6):559-560
pubmed: 33206948
JACC Cardiovasc Imaging. 2020 Aug;13(8):1859
pubmed: 32762893
ESC Heart Fail. 2020 Oct 22;:
pubmed: 33089972
JACC Cardiovasc Imaging. 2020 Nov;13(11):2287-2299
pubmed: 32654963
Int J Cardiovasc Imaging. 2021 Jan;37(1):125-133
pubmed: 33206248
J Am Soc Echocardiogr. 2020 Jun;33(6):648-653
pubmed: 32503700
J Am Coll Cardiol. 2017 Feb 28;69(8):1043-1056
pubmed: 28231932
Front Med. 2020 Jun;14(3):284-292
pubmed: 31858367
Circ Res. 2020 May 8;126(10):1443-1455
pubmed: 32252591
Future Cardiol. 2021 Jul;17(4):655-661
pubmed: 33034203
Infect Disord Drug Targets. 2021;21(8):e160921189885
pubmed: 33397246
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Int J Cardiovasc Imaging. 2021 Jan;37(1):135-144
pubmed: 32803484
Cardiovasc Ultrasound. 2019 Sep 2;17(1):18
pubmed: 31477137
JACC Cardiovasc Imaging. 2020 Aug;13(8):1858-1859
pubmed: 32762891
Echocardiography. 2020 Aug;37(8):1278-1286
pubmed: 32654210
Clin Cardiol. 2021 Oct;44(10):1475-1481
pubmed: 34355809
Pathol Res Pract. 2020 Sep;216(9):153097
pubmed: 32825963
Hypertension. 2014 Mar;63(3):500-6
pubmed: 24396022
J Am Soc Echocardiogr. 2019 Jan;32(1):1-64
pubmed: 30282592